|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02161 JBM HEALTHCARE
Nominal 
1.290 +0.030 (+2.381%) | 2024/03 - Final HKD(K$) | %Chg (Compare to Final) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | 2020/03 HKD(K$) | |
| Turnover | 648,415 | 24.618% | 520,323 | 406,139 | 397,158 | 381,542 |
| Cost of Sales | (310,334) | -1.423% | (314,814) | (244,629) | (198,725) | (191,363) |
| Gross Profit | 338,081 | 64.509% | 205,509 | 161,510 | 198,433 | 190,179 |
| 2024/03 - Final HKD(K$) | %Chg (Compare to Final) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | 2020/03 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | (7,189) | |
| Share of Results of Asso. & JCEs | (817) | -57.734% | (1,933) | (1,791) | (1,186) | 2,963 | |
| Profit / (Loss) before Taxation | 164,890 | 114.427% | 76,898 | 30,745 | 41,681 | 53,966 | |
| Taxation | (27,680) | 103.979% | (13,570) | (7,417) | (11,062) | (9,669) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (6,747) | 8.212% | (6,235) | 1,292 | (8,019) | (3,275) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 130,463 | 128.510% | 57,093 | 24,620 | 22,600 | 41,022 | |
| 2024/03 - Final HKD(K$) | %Chg (Compare to Final) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | 2020/03 HKD(K$) | |
| Net Finance Costs / (Income) | 7,736 | -2.532% | 7,937 | 6,389 | 7,234 | (5,047) |
| Depreciation & Amortisation | 46,521 | 6.621% | 43,632 | 47,783 | 43,602 | 35,862 |
| Directors' Emoluments | 14,391 | 276.531% | 3,822 | 4,406 | 4,201 | 5,372 |
| 2024/03 - Final | %Chg (Compare to Final) | 2023/03 | 2022/03 | 2021/03 | 2020/03 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/03 - Final | %Chg (Compare to Final) | 2023/03 | 2022/03 | 2021/03 | 2020/03 | |
| EPS (cts) | 14.760 | 130.265% | 6.410 | 2.750 | 2.780 | 5.680 |
| DPS (cts) | 7.500 | -- | 3.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | 50.813% | -- | 46.802% | -- | -- | -- |
| Cash flow per share ($) | 0.216 | -- | 0.163 | 0.067 | 0.072 | 0.053 |
| NBV per share ($) | 1.164 | -- | 1.079 | 1.040 | 1.012 | -- |
| Remarks: | Real time quote last updated: 15/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 130,463,000 |
| %Change | 128.510% |
| EPS / (LPS) | HKD 0.148 |
| NBV Per Share ($) | HKD 1.164 |